Olema Pharmaceuticals, Inc. Common Stock (OLMA) Stock
NASDAQ · OLMA
9.82
Fundamentals
Market cap
$859.23M
Price / Earnings ratio
-4.2x
Price / Sales ratio
N/A
Price / Book ratio
2.0x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Olema Pharmaceuticals, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees150
CEODr. Sean P. Bohen M.D., Ph.D.
IPO DateNov 19, 2020
HeadquartersSan Francisco, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Sean P. Bohen M.D., Ph.D. | President, CEO & Director | 1967 |
| Ms. Shawnte M. Mitchell J.D. | Chief Legal Officer & Corporate Secretary | 1978 |
| Mr. Jason O'Byrne M.B.A. | CFO, Principal Financial Officer & Accounting Officer | 1969 |
| Dr. David C. Myles Ph.D. | Chief Scientific Officer | 1963 |
| Ms. Courtney O'Konek | Vice President of Corporate Communications | — |
| Ms. Julie Dexter | Senior VP & Head of People | — |
| Dr. Naseem Zojwalla M.D. | Chief Medical Officer | 1973 |
| Mr. Richard Hernandez | Senior Vice President of Clinical Development Operations | — |
| Dr. Mark Shilkrut M.D., Ph.D. | Senior Vice President of Clinical Development | — |
| Dr. Kamesh Kuchimanchi Ph.D. | Senior Vice President of Regulatory Affairs & Quality Assurance | — |
Fundamentals
Valuation
Market cap$859.23M
Price-to-sales ratioN/A
Price-to-book value2.01
Price-earnings ratio-4.20
Return on Equity-46.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-2.13
Income Statement
Average volume959,111
EBITDA$-183.48M
1 year high (52w)$36.26
1 year low (52w)$6.65
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



